Opioid use may weaken flu shots in HIV patients, study suggests

NCT ID NCT04304768

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how opioid use affects the immune system's response to the flu vaccine in people with and without HIV. Researchers will analyze blood samples from 400 participants to measure antibody levels and immune cell activity. The goal is to understand why opioid users may have weaker immune defenses after vaccination.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Fluzone Quadrivalent (influenza vaccine)

What this could lead to

If successful, this could reveal how opioids impair vaccine effectiveness in people with HIV, guiding better vaccination strategies.

What could go wrong

This is an observational study focused on immune markers, not a treatment trial. Results may not lead to direct clinical changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease immunodeficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Miami

    Miami, Florida, 33136, United States